ENDRA Life Sciences Inc (NDRA)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | TOKMAN, ALEXANDER Y | Director, Chief Executive Officer | Common Stock | Acquisition | 26,921 | 0 |
| Mar 2, 2026 | JACROUX, RICHARD | Chief Financial Officer | Common Stock | Acquisition | 13,461 | 0 |
| Jan 21, 2026 | JACROUX, RICHARD | Chief Financial Officer | Common Stock | Acquisition | 20,000 | 0 |
| Jan 21, 2026 | TOKMAN, ALEXANDER Y | Director, Chief Executive Officer | Common Stock | Acquisition | 75,000 | 0 |
| Jan 21, 2026 | BASENESE, LOU | Director | Common Stock | Acquisition | 60,324 | 0 |
| Jan 21, 2026 | DIGIANDOMENICO, ANTHONY | Director | Common Stock | Acquisition | 60,324 | 0 |
| Jan 21, 2026 | HARSH, MICHAEL | Director | Common Stock | Acquisition | 60,324 | 0 |
| Oct 10, 2025 | DIGIANDOMENICO, ANTHONY | Director | Warrants | Acquisition | 141,644 | 7.06 |
| Oct 10, 2025 | DIGIANDOMENICO, ANTHONY | Director | Common Stock | Acquisition | 70,822 | 7.06 |